Form 4: Shawn McCormick, Director at Inspire Medical Systems, Reports Stock Transactions
SEC Form 4 Filing
Director Shawn McCormick reports exercising stock options and disposing of shares of Inspire Medical Systems.
Summary
- On August 14, 2024, Shawn McCormick, a director at Inspire Medical Systems, exercised stock options to acquire 8,537 shares of common stock at a price of $0.94 per share.
- Following this transaction, McCormick disposed of 8,537 shares.
- McCormick directly owns 23,940 shares of common stock and indirectly owns 3,000 shares through a trust.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions by a company director.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction may have a minor impact on shareholders due to the change in ownership.
Key Dates
| Date | Description |
|---|---|
| 08/14/2024 | Date of transaction: Exercise of stock options and disposal of shares. |
| 08/15/2024 | Date of signature by Attorney-in-Fact. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.